Results 201 to 210 of about 46,788 (276)

Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematology. [PDF]

Front Immunol
Ershova A, Goldaeva A, Staliarova A, Bulatov E, Petukhov A, Barlev N.   +5 more
europepmc   +1 more source

Real‐World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective Study

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Introduction Rituximab is used off‐label for treating cold agglutinin disease (CAD) in the United States; however, real‐world data on its use are limited. Methods This study examined (1) treatment patterns, (2) prespecified safety outcomes, and (3) changes in hemolytic markers post rituximab infusion (threshold change from baseline: hemoglobin
Caroline Piatek, Irina Murakhovskaya, Alia Karaouni, Gandarvaka Miles, Sylvie Bozzi, Carrie Heller, Jacqueline Lucia, Reena Patel, Brad Ward, Ronnie Yoo, Morie Gertz   +10 more
wiley   +1 more source

Acquired aberrant partial CD3 expression in recurrent Epstein-Barr virus-negative solitary plasmacytoma of tonsil. [PDF]

J Pathol Transl Med
Niu C, Ren D, Tran T, Gamayo A, Rezk S, Zhao X.   +5 more
europepmc   +1 more source

The Real World Impact of Immunoglobulin Replacement Therapy on Severe Bacterial Infection for Patients With Hypogammaglobulinemia Secondary to Hematologic Malignancies: A Japanese Claims Database Study

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Objectives The understanding of usefulness of immunoglobulin replacement therapy (IgRT) for hypogammaglobulinemia (HGG) in patients with hematologic malignancies (HM) has changed over time. This is mainly caused by the introduction of new treatment, such as B‐cell targeted agents.
Keichiro Mihara, Takakazu Kawase, Takahiko Miyama, Katsuhiko Iwasaki, Ayako Shoji, Masayuki Matsumaru   +5 more
wiley   +1 more source

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study. [PDF]

Sci Rep
Li X, Liu Y, Zhu X, Jin H, Zhang X, Wang L, Cui Y, Xu F, Wang Y, Song Y, Cui W.   +10 more
europepmc   +1 more source

T‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Background Tumour infiltrating lymphocyte (TIL) T‐cell receptor (TCR) repertoire is prognostic in newly diagnosed diffuse large B‐cell lymphoma (DLBCL), but evolution has not been evaluated at relapse. Methods We examined the TCR repertoire in nine paired DLBCL samples from diagnosis and relapse. Results We noted considerable differences, with
Joel Wight, Tom Witkowski, Colm Keane, Eliza A. Hawkes   +3 more
wiley   +1 more source

CD20 and CD19 promote proliferation driven by the IgM-TLR9-L265P MyD88 complex. [PDF]

Int Immunol
Kobayashi Y, Sato R, Shimizu Y, Fukui R, Shibata T, Tsukamoto H, Tsubata T, Miyake K.   +7 more
europepmc   +1 more source

Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B‐Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to Transplant

eJHaem, Volume 6, Issue 4, August 2025.
Abstract Introduction To ensure response is preserved, it is common practice to continue chemotherapy in patients with large B‐cell lymphoma (LBCL) awaiting autologous hematopoietic stem cell transplant (HSCT), even after they have achieved complete or partial response (CR/PR).
Erin A. Dean, Rick Y. Lin, Tuo Lin, Derek M. Li, Jack W. Hsu, John W. Hiemenz, James W. Lynch Jr, John R. Wingard   +7 more
wiley   +1 more source

Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies. [PDF]

PLoS One
Mizuno T, Kato Y, Tsukui T, Igase M.
europepmc   +1 more source

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo‐Lymphoid Morphology Mimicking Lymphoid Malignancy

American Journal of Hematology, Volume 100, Issue 8, Page 1432-1433, August 2025.
Romain Ravel‐Chapuis, Gérard Buchonnet, Catherine Boutet, Francine Garnache Ottou, Anne Roggy, Florian Renosi, Olivier Matray, Victor Bobée   +7 more
wiley   +1 more source